UCOP

TORL BioTherapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, antibody-based therapies aimed at enhancing the lives of cancer patients. The company specializes in antibody-drug conjugates and other biologics, focusing on oncologic diseases with significant unmet medical needs. TORL BioTherapeutics employs a strategy that involves target identification and early discovery work, allowing them to selectively advance drug programs through novel licensing agreements. This approach enables their researchers to develop proprietary drugs with unique and optimized profiles, contributing to the advancement of cancer treatment options.

Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.